Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 Injection,...
ExploMar Unveils the SUPER/ISLAND Battery Platform to empower 200km range electric water transportation
VENICE, Italy, May 26, 2025 /PRNewswire/ -- As a technology company focused on high-performance electric outboard motor systems, ExploMar has already launched the WAVE 300, WAVE 150+, and WAVE 70+ electric outboard motor systems, along with the 5S...